The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial
Langerhans Cell Histiocytosis (LCH) is a rare disease puzzling both children and adults, however outcome of adult patients is unfavorable. This prospective interventional trial aims to test the efficacy and sa...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Xiao Han, Mingqi Ouyang, Minghui Duan, Wei Zhang, Tienan Zhu, Jian Li, Shujie Wang and Daobin Zhou Tags: Research article Source Type: research
More News: Cancer | Cancer & Oncology | Children | Clinical Trials | Histiocytosis | Langerhans Cell Histiocytosis (LCH) | Methotrexate | Middle East Health | Rare Diseases